136 related articles for article (PubMed ID: 7557247)
1. Enhancement in the protective qualities of gastric mucus by ebrotidine during duodenal ulcer healing.
Slomiany BL; Piotrowski J; Majka J; Czajkowski A; Slomiany A; Gabryelewicz A
Gen Pharmacol; 1995 Sep; 26(5):1039-44. PubMed ID: 7557247
[TBL] [Abstract][Full Text] [Related]
2. Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H. pylori eradication.
Slomiany BL; Piotrowski J; Slomiany A; Konturek JW; Domschke WW
Gen Pharmacol; 1998 Aug; 31(2):227-31. PubMed ID: 9688464
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.
Piotrowski J; Majka J; Piotrowski E; Murty VL; Gabryelewicz A; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1994 Nov; 34(5):875-81. PubMed ID: 7535617
[TBL] [Abstract][Full Text] [Related]
4. Gastroprotective properties of ebrotidine. A review.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
[TBL] [Abstract][Full Text] [Related]
5. Ebrotidine.
Patel SS; Wilde MI
Drugs; 1996 Jun; 51(6):974-80; discussion 981. PubMed ID: 8736619
[TBL] [Abstract][Full Text] [Related]
6. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanol.
Slomiany BL; Piotrowski J; Murty VL; Slomiany A
Gen Pharmacol; 1992 Jul; 23(4):719-27. PubMed ID: 1356875
[TBL] [Abstract][Full Text] [Related]
8. Ebrotidine--a new H2-receptor antagonist with mucosal strengthening activity.
Piotrowski J; Yamaki K; Morita M; Slomiany A; Slomiany BL
Biochem Int; 1992 Mar; 26(4):659-67. PubMed ID: 1351724
[TBL] [Abstract][Full Text] [Related]
9. Gastric mucosal laminin receptor expression with ulcer healing by ebrotidine.
Slomiany BL; Piotrowski J; Czajkowski A; Yotsumoto F; Majka J; Slomiany A
Gen Pharmacol; 1994 May; 25(3):451-5. PubMed ID: 7926589
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine.
Slomiany BL; Piotrowski J; Murty VL; Slomiany A
Gen Pharmacol; 1995 Nov; 26(7):1553-8. PubMed ID: 8690245
[TBL] [Abstract][Full Text] [Related]
11. Enhancement in gastric mucus gel qualities with colloidal bismuth subcitrate administration.
Piotrowski J; Bilski J; Nishikawa H; Slomiany A; Slomiany BL
Eur J Pharmacol; 1990 Aug; 184(1):55-63. PubMed ID: 2209715
[TBL] [Abstract][Full Text] [Related]
12. Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori.
Slomiany BL; Piotrowski J; Mojtahed H; Slomiany A
Gen Pharmacol; 1992 Mar; 23(2):203-6. PubMed ID: 1639232
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle progression during gastric ulcer healing by ebrotidine and sucralfate.
Slomiany BL; Piotrowski J; Slomiany A
Gen Pharmacol; 1997 Sep; 29(3):367-70. PubMed ID: 9378241
[TBL] [Abstract][Full Text] [Related]
14. Effect of ebrotidine on the synthesis and secretion of gastric sulfomucin.
Slomiany BL; Lopez RA; Liau YH; Slomiany A
Gen Pharmacol; 1993 May; 24(3):611-7. PubMed ID: 8365641
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and secretion of gastric sulfomucin in the presence of ebrotidine, a new antiulcer agent.
Slomiany BL; Lopez RA; Slomiany A
Biochem Int; 1992 Dec; 28(4):665-74. PubMed ID: 1482403
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the physicochemical qualities of gastric mucus by sofalcone.
Piotrowski J; Yamaki K; Tamura S; Slomiany A; Slomiany BL
J Physiol Pharmacol; 1991 Sep; 42(3):293-304. PubMed ID: 1793890
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ebrotidine compared with ranitidine in patients with duodenal ulcer.
Gabryelewicz A; Konturek SJ; Butruk E; Dzieniszewski J; Marlicz K; Nowak A; Torres J; Marquez M; Ortiz JA
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):361-6. PubMed ID: 7600143
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of gastric mucus phospholipid secretion by an antiulcer agent, ebrotidine.
Slomiany BL; Piotrowski E; Piotrowski J; Zirvi KA; Liau YH; Murty VL; Slomiany A
Gen Pharmacol; 1994 Sep; 25(5):1033-7. PubMed ID: 7835621
[TBL] [Abstract][Full Text] [Related]
19. Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 1999 Sep; 50(3):391-404. PubMed ID: 10574469
[TBL] [Abstract][Full Text] [Related]
20. Gastroprotective and antisecretory effects of ebrotidine.
Konturek SJ; Maczka J; Kaminski K; Sito E; Torres J; Oleksy J
Scand J Gastroenterol; 1992 Jun; 27(6):438-42. PubMed ID: 1352908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
